How can grafted breast cancer models be optimized?

References

• Malvezzi M, Arfe A, Bertuccio P, Levi F, La Vecchia C, Negri E.. European cancer mortality predictions for the year 2011. Ann Oncol 2011; 22:947 - 56; http://dx.doi.org/10.1093/annonc/mdq774; PMID: 21303801
   PubMed Web of Science ®Google Scholar
• Russo J, Russo IH. Experimentally induced mammary tumors in rats. Breast Cancer Res Treat 1996; 39:7 - 20; http://dx.doi.org/10.1007/BF01806074; PMID: 8738602
   PubMed Web of Science ®Google Scholar
• Mannocci A, De Feo E, de Waure C, Specchia ML, Gualano MR, Barone C, et al. Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies. Tumori 2010; 96:385 - 91; PMID: 20845797
   PubMed Web of Science ®Google Scholar
• Venkatesh S, Lipper RA. Role of the development scientist in compound lead selection and optimization. J Pharm Sci 2000; 89:145 - 54; http://dx.doi.org/10.1002/(SICI)1520-6017(200002)89:2<145::AID-JPS2>3.0.CO;2-6; PMID: 10688744
   PubMed Web of Science ®Google Scholar
• Clarke R. The role of preclinical animal models in breast cancer drug development. Breast Cancer Res 2009; 11:Suppl 3 S22; PMID: 20030874
   PubMedGoogle Scholar
• Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates?. Nat Rev Drug Discov 2004; 3:711 - 5; http://dx.doi.org/10.1038/nrd1470; PMID: 15286737
   PubMed Web of Science ®Google Scholar
• Kinders R, Parchment RE, Ji J, Kummar S, Murgo AJ, Gutierrez M, et al. Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practice. Mol Interv 2007; 7:325 - 34; http://dx.doi.org/10.1124/mi.7.6.9; PMID: 18199854
   PubMed Web of Science ®Google Scholar
• Burchill SA. What do, can and should we learn from models to evaluate potential anticancer agents?. Future Oncol 2006; 2:201 - 11; http://dx.doi.org/10.2217/14796694.2.2.201; PMID: 16563089
   PubMedGoogle Scholar
• Voskoglou-Nomikos T, Pater JL, Seymour L. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res 2003; 9:4227 - 39; PMID: 14519650
   PubMed Web of Science ®Google Scholar
• Hindié E, Groheux D, Brenot-Rossi I, Rubello D, Moretti JL, Espie M. The sentinel node procedure in breast cancer: nuclear medicine as the starting point. J Nucl Med 2011; 52:405 - 14; http://dx.doi.org/10.2967/jnumed.110.081711; PMID: 21321267
   PubMed Web of Science ®Google Scholar
• Fantozzi A, Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Res 2006; 8:212; http://dx.doi.org/10.1186/bcr1530; PMID: 16887003
   PubMed Web of Science ®Google Scholar
• Doré-Savard L, Otis V, Belleville K, Lemire M, Archambault M, Tremblay L, et al. Behavioral, medical imaging and histopathological features of a new rat model of bone cancer pain. PLoS ONE 2010; 5:e13774; http://dx.doi.org/10.1371/journal.pone.0013774; PMID: 21048940
   PubMedGoogle Scholar
• Chia YH, Ellis MJ, Ma CX. Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool. Br J Cancer 2010; 103:759 - 64; http://dx.doi.org/10.1038/sj.bjc.6605845; PMID: 20700118
   PubMed Web of Science ®Google Scholar
• Eroles P, Bosch A, Bermejo B, Lluch A. Mechanisms of resistance to hormonal treatment in breast cancer. Clin Transl Oncol 2010; 12:246 - 52; http://dx.doi.org/10.1007/s12094-010-0500-1; PMID: 20462833
   PubMed Web of Science ®Google Scholar
• Hayes E, Nicholson RI, Hiscox S. Acquired endocrine resistance in breast cancer: implications for tumour metastasis. Front Biosci 2011; 16:838 - 48; http://dx.doi.org/10.2741/3723; PMID: 21196206
   PubMed Web of Science ®Google Scholar
• Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747 - 52; http://dx.doi.org/10.1038/35021093; PMID: 10963602
   PubMed Web of Science ®Google Scholar
• Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98:10869 - 74; http://dx.doi.org/10.1073/pnas.191367098; PMID: 11553815
   PubMed Web of Science ®Google Scholar
• Sørlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003; 100:8418 - 23; http://dx.doi.org/10.1073/pnas.0932692100; PMID: 12829800
   PubMed Web of Science ®Google Scholar
• Thompson HJ, Singh M. Rat models of premalignant breast disease. J Mammary Gland Biol Neoplasia 2000; 5:409 - 20; http://dx.doi.org/10.1023/A:1009582012493; PMID: 14973385
   PubMed Web of Science ®Google Scholar
• Kim IS, Baek SH. Mouse models for breast cancer metastasis. Biochem Biophys Res Commun.
   Google Scholar
• Lacroix M, Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004; 83:249 - 89; http://dx.doi.org/10.1023/B:BREA.0000014042.54925.cc; PMID: 14758095
   PubMed Web of Science ®Google Scholar
• Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 1992; 89:10578 - 82; http://dx.doi.org/10.1073/pnas.89.22.10578; PMID: 1359541
   PubMed Web of Science ®Google Scholar
• Kuperwasser C, Dessain S, Bierbaum BE, Garnet D, Sperandio K, Gauvin GP, et al. A mouse model of human breast cancer metastasis to human bone. Cancer Res 2005; 65:6130 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-04-1408; PMID: 16024614
   PubMed Web of Science ®Google Scholar
• Blouin S, Basle MF, Chappard D. Rat models of bone metastases. Clin Exp Metastasis 2005; 22:605 - 14; http://dx.doi.org/10.1007/s10585-006-9002-5; PMID: 16670964
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhang Z, Guise T, Seth P. Systemic delivery of an oncolytic adenovirus expressing soluble transforming growth factor-beta receptor II-Fc fusion protein can inhibit breast cancer bone metastasis in a mouse model. Hum Gene Ther 2010; 21:1623 - 9; http://dx.doi.org/10.1089/hum.2010.018; PMID: 20712434
   PubMed Web of Science ®Google Scholar
• Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 2005; 11:5678 - 85; http://dx.doi.org/10.1158/1078-0432.CCR-04-2421; PMID: 16115903
   PubMed Web of Science ®Google Scholar
• Andrechek ER, Nevins JR. Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies. J Mol Med 2010; 88:1095 - 100; http://dx.doi.org/10.1007/s00109-010-0644-z; PMID: 20574808
   PubMed Web of Science ®Google Scholar
• Maglione JE, McGoldrick ET, Young LJ, Namba R, Gregg JP, Liu L, et al. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Mol Cancer Ther 2004; 3:941 - 53; PMID: 15299077
   PubMed Web of Science ®Google Scholar
• Meyer DS, Brinkhaus H, Muller U, Muller M, Cardiff RD, Bentires-Alj M. Luminal expression of pik3ca mutant h1047r in the mammary gland induces heterogeneous tumors. Cancer Res 2011; 71:4344 - 51; http://dx.doi.org/10.1158/0008-5472.CAN-10-3827; PMID: 21482677
   PubMed Web of Science ®Google Scholar
• Schneider SL, Fuqua SA, Speeg KV, Tandon AK, McGuire WL. Isolation and characterization of an adriamycin-resistant breast tumor cell line. In Vitro Cell Dev Biol 1990; 26:621 - 8; http://dx.doi.org/10.1007/BF02624212; PMID: 1972704
   PubMed Web of Science ®Google Scholar
• Medina D. Chemical carcinogenesis of rat and mouse mammary glands. Breast Dis 2007; 28:63 - 8; PMID: 18057544
   PubMedGoogle Scholar
• Wang B, Kennan WS, Yasukawa-Barnes J, Lindstrom MJ, Gould MN. Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy. Cancer Res 1992; 52:4102 - 5; PMID: 1353410
   PubMed Web of Science ®Google Scholar
• Gould MN. Rodent models for the study of etiology, prevention and treatment of breast cancer. Semin Cancer Biol 1995; 6:147 - 52; http://dx.doi.org/10.1006/scbi.1995.0023; PMID: 7495982
   PubMed Web of Science ®Google Scholar
• Smits BM, Cotroneo MS, Haag JD, Gould MN. Genetically engineered rat models for breast cancer. Breast Dis 2007; 28:53 - 61; PMID: 18057543
   PubMedGoogle Scholar
• Zarbl H. Toxicogenomic analyses of genetic susceptibility to mammary gland carcinogenesis in rodents: implications for human breast cancer. Breast Dis 2007; 28:87 - 105; PMID: 18057546
   PubMedGoogle Scholar
• Kim JB, O'Hare MJ, Stein R. Models of breast cancer: is merging human and animal models the future?. Breast Cancer Res 2004; 6:22 - 30; http://dx.doi.org/10.1186/bcr645; PMID: 14680482
   PubMed Web of Science ®Google Scholar
• Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol 2011; 223:307 - 17; http://dx.doi.org/10.1002/path.2808; PMID: 21125683
   PubMed Web of Science ®Google Scholar
• Russo J, Russo IH. Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 2000; 5:187 - 200; http://dx.doi.org/10.1023/A:1026443305758; PMID: 11149572
   PubMed Web of Science ®Google Scholar
• Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 1995; 92:3650 - 7; http://dx.doi.org/10.1073/pnas.92.9.3650; PMID: 7731959
   PubMed Web of Science ®Google Scholar
• Huang G, Tong C, Kumbhani DS, Ashton C, Yan H, Ying QL. Beyond knockout rats: new insights into finer genome manipulation in rats. Cell Cycle 2011; 10:1059 - 66; http://dx.doi.org/10.4161/cc.10.7.15233; PMID: 21383544
   PubMed Web of Science ®Google Scholar
• Matsuoka Y, Hamaguchi T, Fukamachi K, Yoshida M, Watanabe G, Taya K, et al. Molecular analysis of rat mammary carcinogenesis: an approach from carcinogenesis research to cancer prevention. Med Mol Morphol 2007; 40:185 - 90; http://dx.doi.org/10.1007/s00795-007-0369-4; PMID: 18085376
   PubMed Web of Science ®Google Scholar
• Pagès F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010; 29:1093 - 102; http://dx.doi.org/10.1038/onc.2009.416; PMID: 19946335
   PubMed Web of Science ®Google Scholar
• de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006; 6:24 - 37; http://dx.doi.org/10.1038/nrc1782; PMID: 16397525
   PubMed Web of Science ®Google Scholar
• Bosma MJ, Carroll AM. The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol 1991; 9:323 - 50; http://dx.doi.org/10.1146/annurev.iy.09.040191.001543; PMID: 1910681
   PubMed Web of Science ®Google Scholar
• Carroll AM, Bosma MJ. T-lymphocyte development in scid mice is arrested shortly after the initiation of T-cell receptor delta gene recombination. Genes Dev 1991; 5:1357 - 66; http://dx.doi.org/10.1101/gad.5.8.1357; PMID: 1869046
   PubMed Web of Science ®Google Scholar
• Fridman R, Kibbey MC, Royce LS, Zain M, Sweeney M, Jicha DL, et al. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel. J Natl Cancer Inst 1991; 83:769 - 74; http://dx.doi.org/10.1093/jnci/83.11.769; PMID: 1789823
   PubMed Web of Science ®Google Scholar
• Steel GG, Courtenay VD, Rostom AY. Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer 1978; 37:224 - 30; http://dx.doi.org/10.1038/bjc.1978.30; PMID: 343803
   PubMed Web of Science ®Google Scholar
• Goodman MM, McCullough JL, Biren CA, Barr RJ. A model of human melanoma in cyclosporine-immunosuppressed rats. J Invest Dermatol 1987; 88:141 - 4; http://dx.doi.org/10.1111/1523-1747.ep12525289; PMID: 3492567
   PubMed Web of Science ®Google Scholar
• Denkert C, Darb-Esfahani S, Loibl S, Anagnostopoulos I, Johrens K. Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy. Semin Immunopathol 2011.
   Google Scholar
• Carson WE 3rd, Shapiro CL, Crespin TR, Thornton LM, Andersen BL. Cellular immunity in breast cancer patients completing taxane treatment. Clin Cancer Res 2004; 10:3401 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-1016-03; PMID: 15161695
   PubMed Web of Science ®Google Scholar
• Chan OT, Yang LX. The immunological effects of taxanes. Cancer Immunol Immunother 2000; 49:181 - 5; http://dx.doi.org/10.1007/s002620000122; PMID: 10941900
   PubMed Web of Science ®Google Scholar
• Santosuosso M, Divangahi M, Zganiacz A, Xing Z. Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage-colony-stimulating factor gene transfer. Blood 2002; 99:1246 - 52; http://dx.doi.org/10.1182/blood.V99.4.1246; PMID: 11830472
   PubMed Web of Science ®Google Scholar
• Xia TS, Wang J, Yin H, Ding Q, Zhang YF, Yang HW, et al. Human tissue-specific microenvironment: an essential requirement for mouse models of breast cancer. Oncol Rep 2010; 24:203 - 11; PMID: 20514463
   PubMed Web of Science ®Google Scholar
• Wagner KU. Models of breast cancer: quo vadis, animal modeling?. Breast Cancer Res 2004; 6:31 - 8; http://dx.doi.org/10.1186/bcr723; PMID: 14680483
   PubMed Web of Science ®Google Scholar
• Vernon AE, Bakewell SJ, Chodosh LA. Deciphering the molecular basis of breast cancer metastasis with mouse models. Rev Endocr Metab Disord 2007; 8:199 - 213; http://dx.doi.org/10.1007/s11154-007-9041-5; PMID: 17657606
   PubMed Web of Science ®Google Scholar
• Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992; 52:1399 - 405; PMID: 1540948
   PubMed Web of Science ®Google Scholar
• Tao K, Fang M, Alroy J, Sahagian GG. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 2008; 8:228; http://dx.doi.org/10.1186/1471-2407-8-228; PMID: 18691423
   PubMed Web of Science ®Google Scholar
• Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Protoc Immunol 2001; Chapter 20:Unit 20 2.
   Google Scholar
• Chumsri S, Howes T, Bao T, Sabnis G, Brodie A. Aromatase, aromatase inhibitors, and breast cancer. J Steroid Biochem Mol Biol 2011; 125:13 - 22; http://dx.doi.org/10.1016/j.jsbmb.2011.02.001; PMID: 21335088
   PubMed Web of Science ®Google Scholar
• Lipton A, Santen RJ, Santner SJ, Harvey HA, Sanders SI, Matthews YL. Prognostic value of breast cancer aromatase. Cancer 1992; 70:1951 - 5; http://dx.doi.org/10.1002/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-#; PMID: 1525771
   PubMed Web of Science ®Google Scholar
• Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, et al. Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 2000; 95 - 112; PMID: 10963622
   PubMedGoogle Scholar
• Yue W, Wang JP, Hamilton CJ, Demers LM, Santen RJ. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res 1998; 58:927 - 32; PMID: 9500452
   PubMed Web of Science ®Google Scholar
• Ferguson AT, Davidson NE. Regulation of estrogen receptor alpha function in breast cancer. Crit Rev Oncog 1997; 8:29 - 46; PMID: 9516085
   PubMed Web of Science ®Google Scholar
• Cavalieri E, Rogan E. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Ann N Y Acad Sci 2006; 1089:286 - 301; http://dx.doi.org/10.1196/annals.1386.042; PMID: 17261777
   PubMed Web of Science ®Google Scholar
• Santen R. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann N Y Acad Sci 2009; 1155:132 - 40; http://dx.doi.org/10.1111/j.1749-6632.2008.03685.x; PMID: 19250200
   PubMed Web of Science ®Google Scholar
• Clevenger CV, Gadd SL, Zheng J. New mechanisms for PRLr action in breast cancer. Trends Endocrinol Metab 2009; 20:223 - 9; http://dx.doi.org/10.1016/j.tem.2009.03.001; PMID: 19535262
   PubMed Web of Science ®Google Scholar
• Maus MV, Reilly SC, Clevenger CV. Prolactin as a chemoattractant for human breast carcinoma. Endocrinology 1999; 140:5447 - 50; http://dx.doi.org/10.1210/en.140.11.5447; PMID: 10537179
   PubMed Web of Science ®Google Scholar
• Perks CM, Keith AJ, Goodhew KL, Savage PB, Winters ZE, Holly JM. Prolactin acts as a potent survival factor for human breast cancer cell lines. 2005. Br J Cancer 2004; 91:305 - 11; http://dx.doi.org/10.1038/sj.bjc.6601947; PMID: 15213724
   PubMed Web of Science ®Google Scholar
• Lunt SJ, Kalliomaki TM, Brown A, Yang VX, Milosevic M, Hill RP. Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours. BMC Cancer 2008; 8:2; http://dx.doi.org/10.1186/1471-2407-8-2; PMID: 18179711
   PubMed Web of Science ®Google Scholar
• Wilmanns C, Fan D, O'Brian CA, Bucana CD, Fidler IJ. Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer 1992; 52:98 - 104; http://dx.doi.org/10.1002/ijc.2910520118; PMID: 1500231
   PubMed Web of Science ®Google Scholar
• Zechmann CM, Woenne EC, Brix G, Radzwill N, Ilg M, Bachert P, et al. Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors. Neoplasia 2007; 9:57 - 67; http://dx.doi.org/10.1593/neo.06688; PMID: 17325744
   PubMed Web of Science ®Google Scholar
• Tsuzuki Y, Mouta Carreira C, Bockhorn M, Xu L, Jain RK, Fukumura D. Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab Invest 2001; 81:1439 - 51; PMID: 11598156
   PubMed Web of Science ®Google Scholar
• Franco OE, Shaw AK, Strand DW, Hayward SW. Cancer associated fibroblasts in cancer pathogenesis. Semin Cell Dev Biol 2010; 21:33 - 9; http://dx.doi.org/10.1016/j.semcdb.2009.10.010; PMID: 19896548
   PubMed Web of Science ®Google Scholar
• Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432:332 - 7; http://dx.doi.org/10.1038/nature03096; PMID: 15549095
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141:52 - 67; http://dx.doi.org/10.1016/j.cell.2010.03.015; PMID: 20371345
   PubMed Web of Science ®Google Scholar
• Radisky ES, Radisky DC. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 2010; 15:201 - 12; http://dx.doi.org/10.1007/s10911-010-9177-x; PMID: 20440544
   PubMed Web of Science ®Google Scholar
• Gialeli C, Theocharis AD, Karamanos NK. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 2011; 278:16 - 27; http://dx.doi.org/10.1111/j.1742-4658.2010.07919.x; PMID: 21087457
   PubMed Web of Science ®Google Scholar
• Pupa SM, Menard S, Forti S, Tagliabue E. New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol 2002; 192:259 - 67; http://dx.doi.org/10.1002/jcp.10142; PMID: 12124771
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860 - 7; http://dx.doi.org/10.1038/nature01322; PMID: 12490959
   PubMed Web of Science ®Google Scholar
• Cole LK, Jacobs RL, Vance DE. Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis. Hepatology.
   Google Scholar
• Tabruyn SP, Griffioen AW. Molecular pathways of angiogenesis inhibition. Biochem Biophys Res Commun 2007; 355:1 - 5; http://dx.doi.org/10.1016/j.bbrc.2007.01.123; PMID: 17276388
   PubMed Web of Science ®Google Scholar
• Döme B, Hendrix MJ, Paku S, Tovari J, Timar J. Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. Am J Pathol 2007; 170:1 - 15; PMID: 17200177
   PubMed Web of Science ®Google Scholar
• Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411:342 - 8; http://dx.doi.org/10.1038/35077213; PMID: 11357141
   PubMed Web of Science ®Google Scholar
• Chen JH, Lin YC, Huang YS, Chen TJ, Lin WY, Han KW. Induction of VX2 carcinoma in rabbit liver: comparison of two inoculation methods. Lab Anim 2004; 38:79 - 84; http://dx.doi.org/10.1258/00236770460734434; PMID: 14979992
   PubMed Web of Science ®Google Scholar
• Fei XF, Zhang QB, Dong J, Diao Y, Wang ZM, Li RJ, et al. Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar. J Exp Clin Cancer Res 2010; 29:84; http://dx.doi.org/10.1186/1756-9966-29-84; PMID: 20587035
   PubMed Web of Science ®Google Scholar
• Thorstensen O, Isberg B, Svahn U, Jorulf H, Venizelos N, Jaremko G. Experimental tissue transplantation using a biopsy instrument and radiologic methods. Invest Radiol 1994; 29:469 - 71; http://dx.doi.org/10.1097/00004424-199404000-00015; PMID: 8034455
   PubMed Web of Science ®Google Scholar
• Carlsson G, Gullberg B, Hafstrom L. Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol 1983; 105:20 - 3; http://dx.doi.org/10.1007/BF00391826; PMID: 6833336
   PubMed Web of Science ®Google Scholar
• Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24:148 - 54; http://dx.doi.org/10.1007/BF00300234; PMID: 2544306
   PubMed Web of Science ®Google Scholar
• O'Neill K, Lyons SK, Gallagher WM, Curran KM, Byrne AT. Bioluminescent imaging: a critical tool in pre-clinical oncology research. J Pathol 2010; 220:317 - 27; PMID: 19967724
   PubMed Web of Science ®Google Scholar
• Bremer C, Ntziachristos V, Weissleder R. Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol 2003; 13:231 - 43; PMID: 12598985
   PubMed Web of Science ®Google Scholar
• Tiffen JC, Bailey CG, Ng C, Rasko JE, Holst J. Luciferase expression and bioluminescence does not affect tumor cell growth in vitro or in vivo. Mol Cancer 2010; 9:299; http://dx.doi.org/10.1186/1476-4598-9-299; PMID: 21092230
   PubMed Web of Science ®Google Scholar
• Sanz L, Santos-Valle P, Alonso-Camino V, Salas C, Serrano A, Vicario JL, et al. Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels. Microvasc Res 2008; 75:308 - 14; http://dx.doi.org/10.1016/j.mvr.2007.11.007; PMID: 18252255
   PubMed Web of Science ®Google Scholar
• Hong H, Yang Y, Zhang Y, Cai W. Non-invasive cell tracking in cancer and cancer therapy. Curr Top Med Chem 2010; 10:1237 - 48; http://dx.doi.org/10.2174/156802610791384234; PMID: 20388105
   PubMed Web of Science ®Google Scholar
• Naik S, Piwnica-Worms D. Real-time imaging of beta-catenin dynamics in cells and living mice. Proc Natl Acad Sci USA 2007; 104:17465 - 70; http://dx.doi.org/10.1073/pnas.0704465104; PMID: 17954915
   PubMed Web of Science ®Google Scholar
• Koba W, Kim K, Lipton ML, Jelicks L, Das B, Herbst L, et al. Imaging devices for use in small animals. Semin Nucl Med 2011; 41:151 - 65; http://dx.doi.org/10.1053/j.semnuclmed.2010.12.003; PMID: 21440693
   PubMed Web of Science ®Google Scholar
• Piatkevich KD, Verkhusha VV. Advances in engineering of fluorescent proteins and photoactivatable proteins with red emission. Curr Opin Chem Biol 2010; 14:23 - 9; http://dx.doi.org/10.1016/j.cbpa.2009.10.011; PMID: 19914857
   PubMed Web of Science ®Google Scholar
• Shu X, Royant A, Lin MZ, Aguilera TA, Lev-Ram V, Steinbach PA, et al. Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science 2009; 324:804 - 7; http://dx.doi.org/10.1126/science.1168683; PMID: 19423828
   PubMed Web of Science ®Google Scholar
• Nguyen QT, Olson ES, Aguilera TA, Jiang T, Scadeng M, Ellies LG, et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci USA 2010; 107:4317 - 22; http://dx.doi.org/10.1073/pnas.0910261107; PMID: 20160097
   PubMed Web of Science ®Google Scholar
• Olson ES, Jiang T, Aguilera TA, Nguyen QT, Ellies LG, Scadeng M, et al. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc Natl Acad Sci USA 2010; 107:4311 - 6; http://dx.doi.org/10.1073/pnas.0910283107; PMID: 20160077
   PubMed Web of Science ®Google Scholar
• Ting R, Aguilera TA, Crisp JL, Hall DJ, Eckelman WC, Vera DR, et al. Fast 18F labeling of a near-infrared fluorophore enables positron emission tomography and optical imaging of sentinel lymph nodes. Bioconjug Chem 2010; 21:1811 - 9; http://dx.doi.org/10.1021/bc1001328; PMID: 20873712
   PubMed Web of Science ®Google Scholar
• Holdsworth DW. Micro-CT in small animal and specimen imaging. Trends Biotechnol 2002.
   Google Scholar
• Dufort S, Sancey L, Wenk C, Josserand V, Coll JL. Optical small animal imaging in the drug discovery process. Biochim Biophys Acta 2010; 1798:2266 - 73; http://dx.doi.org/10.1016/j.bbamem.2010.03.016; PMID: 20346346
   PubMed Web of Science ®Google Scholar
• Levin CS. Primer on molecular imaging technology. Eur J Nucl Med Mol Imaging 2005; 32:Suppl 2 S325 - 45; http://dx.doi.org/10.1007/s00259-005-1973-y; PMID: 16341514
   PubMed Web of Science ®Google Scholar
• Monteil J, Dutour A, Akla B, Chianea T, Le Brun V, Grossin L, et al. In vivo follow-up of rat tumor models with 2-deoxy-2-[F-18]fluoro-D-glucose/dual-head coincidence gamma camera imaging. Mol Imaging Biol 2005; 7:220 - 8; http://dx.doi.org/10.1007/s11307-005-4115-9; PMID: 15912426
   PubMed Web of Science ®Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205 - 16; http://dx.doi.org/10.1093/jnci/92.3.205; PMID: 10655437
   PubMed Web of Science ®Google Scholar
• Padhani AR, Ollivier L. The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists. Br J Radiol 2001; 74:983 - 6; PMID: 11709461
   PubMed Web of Science ®Google Scholar
• Blanco MA, Kang Y. Signaling pathways in breast cancer metastasis - novel insights from functional genomics. Breast Cancer Res 2011; 13:206; http://dx.doi.org/10.1186/bcr2831; PMID: 21457525
   PubMed Web of Science ®Google Scholar
• Goodison S, Sun Y, Urquidi V. Derivation of cancer diagnostic and prognostic signatures from gene expression data. Bioanalysis 2010; 2:855 - 62; http://dx.doi.org/10.4155/bio.10.35; PMID: 21083217
   PubMed Web of Science ®Google Scholar
• Polyak K. Molecular markers for the diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010; 2010:210 - 3; http://dx.doi.org/10.1093/jncimonographs/lgq019; PMID: 20956832
   PubMedGoogle Scholar
• Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344:783 - 92; http://dx.doi.org/10.1056/NEJM200103153441101; PMID: 11248153
   PubMed Web of Science ®Google Scholar
• Hattori N, Okochi-Takada E, Kikuyama M, Wakabayashi M, Yamashita S, Ushijima T. Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas. Cancer Sci 2011; 102:1337 - 43; http://dx.doi.org/10.1111/j.1349-7006.2011.01955.x; PMID: 21489049
   PubMed Web of Science ®Google Scholar
• Demircan B, Dyer LM, Gerace M, Lobenhofer EK, Robertson KD, Brown KD. Comparative epigenomics of human and mouse mammary tumors. Genes Chromosomes Cancer 2009; 48:83 - 97; http://dx.doi.org/10.1002/gcc.20620; PMID: 18836996
   PubMed Web of Science ®Google Scholar
• Szpirer C.. Cancer research in rat models. Methods Mol Biol 2010; 597:445 - 58; http://dx.doi.org/10.1007/978-1-60327-389-3_30; PMID: 20013251
   PubMedGoogle Scholar
• Coleman RE. Future directions in the treatment and prevention of bone metastases. Am J Clin Oncol 2002; 25:S32 - 8; http://dx.doi.org/10.1097/00000421-200212001-00006; PMID: 12562049
   PubMedGoogle Scholar
• Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002; 2:584 - 93; http://dx.doi.org/10.1038/nrc867; PMID: 12154351
   PubMed Web of Science ®Google Scholar
• Engel LW, Young NA. Human breast carcinoma cells in continuous culture: a review. Cancer Res 1978; 38:4327 - 39; PMID: 212193
   PubMed Web of Science ®Google Scholar
• Chow LW, Cheung MN, Loo WT, Guan XY. A rat cell line derived from DMBA-induced mammary carcinoma. Life Sci 2003; 73:27 - 40; http://dx.doi.org/10.1016/S0024-3205(03)00253-4; PMID: 12726884
   PubMed Web of Science ®Google Scholar
• Eil C, Douglass EC, Rosenburg SM, Kano-Sueoka T. Receptor characteristics of the rat mammary carcinoma cell line 64-24. Cancer Res 1981; 41:42 - 8; PMID: 6256064
   PubMed Web of Science ®Google Scholar
• Oikawa T, Matsuzawa A, Iwaguchi T. Progression from hormone dependence to autonomy and angiogenesis in mouse mammary tumours. Br J Cancer 1986; 54:91 - 6; http://dx.doi.org/10.1038/bjc.1986.156; PMID: 2425838
   PubMed Web of Science ®Google Scholar
• Nakanishi H, Taylor RM, Chrest FJ, Masui T, Utsumi K, Tatematsu M, et al. Progression of hormone-dependent adenocarcinoma cells to hormone-independent spindle carcinoma cells in vitro in a clonal spontaneous rat mammary tumor cell line. Cancer Res 1995; 55:399 - 407; PMID: 7529136
   PubMed Web of Science ®Google Scholar
• Peterson JK, Houghton PJ. Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development. Eur J Cancer 2004; 40:837 - 44; http://dx.doi.org/10.1016/j.ejca.2004.01.003; PMID: 15120039
   PubMed Web of Science ®Google Scholar
• Paoloni M, Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008; 8:147 - 56; http://dx.doi.org/10.1038/nrc2273; PMID: 18202698
   PubMed Web of Science ®Google Scholar
• Knapp DW, Waters DJ. Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans. Mol Med Today 1997; 3:8 - 11; http://dx.doi.org/10.1016/S1357-4310(96)20031-0; PMID: 9021736
   PubMedGoogle Scholar
• Gordon I, Paoloni M, Mazcko C, Khanna C. The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway. PLoS Med 2009; 6:e1000161; http://dx.doi.org/10.1371/journal.pmed.1000161; PMID: 19823573
   PubMed Web of Science ®Google Scholar